45.35
BATS BZX Real-Time Price
As of 10:09am ET
 -0.03 / -0.07%
Today’s Change
29.56
Today|||52-Week Range
46.81
+25.00%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close45.38
Today’s open45.19
Day’s range45.15 - 45.44
Volume1,073
Average volume (3 months)297,300
Market cap$1.8B
Data as of 10:09am ET, 06/20/2018

Growth & Valuation

Earnings growth (last year)+111.76%
Earnings growth (this year)+2.21%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+35.10%
P/E ratio63.9
Price/Sales10.06
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
MYOKMyoKardia Inc+0.40+0.83%
ARRYArray Biopharma Inc+0.22+1.16%
LXRXLexicon Pharmaceutic...-0.12-0.89%
EBSEmergent BioSolution...+0.02+0.04%
Data as of 10:09am ET, 06/20/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$0.19
Annual revenue (last year)$141.2M
Annual profit (last year)$28.4M
Net profit margin20.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts